- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.02 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 1 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 12 residues within 4Å:- Chain B: S.319, N.320, A.321, D.337, R.338, V.339, L.469, G.472, E.473, I.476
- Ligands: EDO.6, EDO.9
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain B: D.207, A.321, E.322, I.325, H.326
- Ligands: EDO.6, EDO.9
Ligand excluded by PLIPEDO.6: 8 residues within 4Å:- Chain B: Q.203, A.204, A.321, K.340, E.473
- Ligands: EDO.4, EDO.5, EDO.9
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain B: A.362, A.381, I.410
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain B: D.115, I.116, K.117, D.304, F.305, R.306
Ligand excluded by PLIPEDO.9: 8 residues within 4Å:- Chain B: S.319, E.322, R.338, V.339, K.340
- Ligands: EDO.4, EDO.5, EDO.6
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain B: L.454, H.457, D.458, L.459, K.464
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: Y.4, P.5, I.6
- Chain B: Q.259, I.260, P.261, V.268
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain B: D.337, F.374, G.472, E.475, I.476
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain B: P.43, E.48, E.51, H.206, F.209, S.210, K.213
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain B: R.63, K.64, Q.66
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain B: I.27, Q.66, Y.223, S.240, F.241, T.242
- Ligands: EDO.18
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain B: F.330, V.461, K.464, M.465, K.468
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain B: L.402, G.403, D.404, S.405, A.406, R.409
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain B: Y.223, I.226, Q.227, L.237, K.238, F.241
- Ligands: EDO.15
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: L.343, G.344, F.390, R.435
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain B: R.77, G.107, F.108
- Ligands: SAH.2
Ligand excluded by PLIPEDO.21: 1 residues within 4Å:- Chain B: D.404
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: E.376, P.377, S.483, N.487
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain B: A.118, E.119, E.120
Ligand excluded by PLIP- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dai, S. et al., An engineered variant of SETD3 methyltransferase alters target specificity from histidine to lysine methylation. J.Biol.Chem. (2020)
- Release Date
- 2020-01-22
- Peptides
- Actin, cytoplasmic 1: A
Actin-histidine N-methyltransferase: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
YB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.02 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 1 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dai, S. et al., An engineered variant of SETD3 methyltransferase alters target specificity from histidine to lysine methylation. J.Biol.Chem. (2020)
- Release Date
- 2020-01-22
- Peptides
- Actin, cytoplasmic 1: A
Actin-histidine N-methyltransferase: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
YB
A